NCT06149208View on ClinicalTrials.gov

Emergency Department Discharge for Type II Supracondylar Fractures - PROSPR Phase 5

Not yet recruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

June 1, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

June 28, 2026

Conditions
Supracondylar Fracture
Interventions
BEHAVIORAL

Interview

Families will complete interviews about their experiences with the new treatment standard and managing pain at home

Trial Locations (1)

M5G 1X8

The Hospital for Sick Children, Toronto

All Listed Sponsors
lead

The Hospital for Sick Children

OTHER

NCT06149208 - Emergency Department Discharge for Type II Supracondylar Fractures - PROSPR Phase 5 | Biotech Hunter | Biotech Hunter